Toni Shippenberg, Ph.D. - Publications

Affiliations: 
National Institute on Drug Abuse 
Area:
Drug addiction

171 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S. Modulation of serotonin transporter function by kappa-opioid receptor ligands. Neuropharmacology. PMID 27743931 DOI: 10.1016/j.neuropharm.2016.10.011  0.36
2015 Mannangatti P, NarasimhaNaidu K, Damaj MI, Ramamoorthy S, Jayanthi LD. A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference. The Journal of Biological Chemistry. 290: 10814-27. PMID 25724654 DOI: 10.1074/jbc.M114.612192  0.36
2014 Henriksson R, Bäckman CM, Harvey BK, Kadyrova H, Bazov I, Shippenberg TS, Bakalkin G. PDYN, a gene implicated in brain/mental disorders, is targeted by REST in the adult human brain. Biochimica Et Biophysica Acta. 1839: 1226-32. PMID 25220237 DOI: 10.1016/j.bbagrm.2014.09.001  0.36
2014 Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, ... ... Shippenberg TS, et al. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40. PMID 25107591 DOI: 10.1016/j.neuropharm.2014.07.016  0.36
2013 Kuzmin A, Chefer V, Bazov I, Meis J, Ögren SO, Shippenberg T, Bakalkin G. Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment. Translational Psychiatry. 3: e310. PMID 24105441 DOI: 10.1038/tp.2013.72  0.36
2013 Chefer VI, Bäckman CM, Gigante ED, Shippenberg TS. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2623-31. PMID 23921954 DOI: 10.1038/npp.2013.171  0.36
2013 Tejeda HA, Counotte DS, Oh E, Ramamoorthy S, Schultz-Kuszak KN, Bäckman CM, Chefer V, O'Donnell P, Shippenberg TS. Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1770-9. PMID 23542927 DOI: 10.1038/npp.2013.76  0.36
2013 Mousa SA, Shaqura M, Khalefa BI, Zöllner C, Schaad L, Schneider J, Shippenberg TS, Richter JF, Hellweg R, Shakibaei M, Schäfer M. Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy. Diabetes. 62: 1308-19. PMID 23230081 DOI: 10.2337/db12-0590  0.36
2012 Zapata A, Pontis S, Schepers RJ, Wang R, Oh E, Stein A, Bäckman CM, Worley P, Enguita M, Abad MA, Trullas R, Shippenberg TS. Alleviation of neuropathic pain hypersensitivity by inhibiting neuronal pentraxin 1 in the rostral ventromedial medulla. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 12431-6. PMID 22956834 DOI: 10.1523/JNEUROSCI.2730-12.2012  0.36
2012 Kuzmin A, Liljequist S, Meis J, Chefer V, Shippenberg T, Bakalkin G. Repeated moderate-dose ethanol bouts impair cognitive function in Wistar rats. Addiction Biology. 17: 132-40. PMID 22026443 DOI: 10.1111/j.1369-1600.2010.00224.x  0.36
2012 Tejeda HA, Shippenberg TS, Henriksson R. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cellular and Molecular Life Sciences : Cmls. 69: 857-96. PMID 22002579 DOI: 10.1007/s00018-011-0844-x  0.36
2012 Annamalai B, Mannangatti P, Arapulisamy O, Shippenberg TS, Jayanthi LD, Ramamoorthy S. Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function. Molecular Pharmacology. 81: 73-85. PMID 21992875 DOI: 10.1124/mol.111.073171  0.36
2012 Oz M, Isaev D, Lorke DE, Hasan M, Petroianu G, Shippenberg TS. Methylene blue inhibits function of the 5-HT transporter. British Journal of Pharmacology. 166: 168-76. PMID 21542830 DOI: 10.1111/j.1476-5381.2011.01462.x  0.36
2011 Bagley EE, Hacker J, Chefer VI, Mallet C, McNally GP, Chieng BC, Perroud J, Shippenberg TS, Christie MJ. Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nature Neuroscience. 14: 1548-54. PMID 22037500 DOI: 10.1038/nn.2940  0.36
2011 Chefer VI, Wang R, Shippenberg TS. Basolateral amygdala-driven augmentation of medial prefrontal cortex GABAergic neurotransmission in response to environmental stimuli associated with cocaine administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2018-29. PMID 21633339 DOI: 10.1038/npp.2011.89  0.36
2011 Mannangatti P, Arapulisamy O, Shippenberg TS, Ramamoorthy S, Jayanthi LD. Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase. The Journal of Biological Chemistry. 286: 20239-50. PMID 21498515 DOI: 10.1074/jbc.M111.226811  0.36
2011 Good CH, Hoffman AF, Hoffer BJ, Chefer VI, Shippenberg TS, Bäckman CM, Larsson NG, Olson L, Gellhaar S, Galter D, Lupica CR. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 1333-44. PMID 21233488 DOI: 10.1096/fj.10-173625  0.36
2011 Chefer V, Meis J, Wang G, Kuzmin A, Bakalkin G, Shippenberg T. Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release. Addiction Biology. 16: 229-37. PMID 21182572 DOI: 10.1111/j.1369-1600.2010.00272.x  0.36
2011 Ramamoorthy S, Shippenberg TS, Jayanthi LD. Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacology & Therapeutics. 129: 220-38. PMID 20951731 DOI: 10.1016/j.pharmthera.2010.09.009  0.36
2011 Kaminski RM, Núñez-Taltavull JF, Budziszewska B, LasoÅ„ W, Gasior M, Zapata A, Shippenberg TS, Witkin JM. Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain. Neurochemical Research. 36: 146-52. PMID 20927585 DOI: 10.1007/s11064-010-0284-2  0.36
2010 Zapata A, Minney VL, Shippenberg TS. Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15457-63. PMID 21084602 DOI: 10.1523/JNEUROSCI.4072-10.2010  0.36
2010 Wang J, Carnicella S, Ahmadiantehrani S, He DY, Barak S, Kharazia V, Ben Hamida S, Zapata A, Shippenberg TS, Ron D. Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14502-12. PMID 20980608 DOI: 10.1523/JNEUROSCI.3909-10.2010  0.36
2010 Oz M, Libby T, Kivell B, Jaligam V, Ramamoorthy S, Shippenberg TS. Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+. Journal of Neurochemistry. 114: 1019-29. PMID 20524964 DOI: 10.1111/j.1471-4159.2010.06828.x  0.36
2010 Tejeda HA, Chefer VI, Zapata A, Shippenberg TS. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat. Psychopharmacology. 210: 231-40. PMID 20232058 DOI: 10.1007/s00213-010-1799-6  0.36
2010 Yang KH, Galadari S, Isaev D, Petroianu G, Shippenberg TS, Oz M. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes. The Journal of Pharmacology and Experimental Therapeutics. 333: 547-54. PMID 20160007 DOI: 10.1124/jpet.109.162594  0.36
2010 Oz M, Jaligam V, Galadari S, Petroianu G, Shuba YM, Shippenberg TS. The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism. Journal of Neurochemistry. 112: 1454-64. PMID 20050977 DOI: 10.1111/j.1471-4159.2009.06557.x  0.36
2009 Chefer VI, Denoroy L, Zapata A, Shippenberg TS. Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms. The European Journal of Neuroscience. 30: 272-8. PMID 19614973 DOI: 10.1111/j.1460-9568.2009.06827.x  0.36
2009 Zapata A, Chefer VI, Shippenberg TS, Denoroy L. Detection and quantification of neurotransmitters in dialysates. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 7.4.1-30. PMID 19575473 DOI: 10.1002/0471142301.ns0704s48  0.36
2009 Zapata A, Chefer VI, Shippenberg TS. Microdialysis in rodents. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit7.2. PMID 19340813 DOI: 10.1002/0471142301.ns0702s47  0.36
2009 Chefer VI, Thompson AC, Zapata A, Shippenberg TS. Overview of brain microdialysis. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit7.1. PMID 19340812 DOI: 10.1002/0471142301.ns0701s47  0.36
2009 Cassano T, Gaetani S, Morgese MG, Macheda T, Laconca L, Dipasquale P, Taltavull J, Shippenberg TS, Cuomo V, Gobbi G. Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochemical Research. 34: 1417-26. PMID 19229609 DOI: 10.1007/s11064-009-9928-5  0.36
2009 Shippenberg TS. The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 247. PMID 19079072 DOI: 10.1038/npp.2008.165  0.36
2009 Shippenberg TS, Chefer VI, Thompson AC. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biological Psychiatry. 65: 169-74. PMID 18950747 DOI: 10.1016/j.biopsych.2008.09.009  0.36
2009 Chefer VI, Shippenberg TS. Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 887-98. PMID 18704097 DOI: 10.1038/npp.2008.128  0.36
2008 Shippenberg TS, LeFevour A, Chefer VI. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. Cns & Neurological Disorders Drug Targets. 7: 442-53. PMID 19128202 DOI: 10.2174/187152708786927813  0.36
2008 Schepers RJ, Mahoney JL, Gehrke BJ, Shippenberg TS. Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation. Pain. 138: 423-39. PMID 18355964 DOI: 10.1016/j.pain.2008.01.023  0.36
2008 Gehrke BJ, Chefer VI, Shippenberg TS. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology. 197: 509-17. PMID 18246329 DOI: 10.1007/s00213-007-1067-6  0.36
2008 Jackson SN, Singhal SK, Woods AS, Morales M, Shippenberg T, Zhang L, Oz M. Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. European Journal of Pharmacology. 582: 42-51. PMID 18242598 DOI: 10.1016/j.ejphar.2007.12.023  0.36
2008 Butt C, Alptekin A, Shippenberg T, Oz M. Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. Journal of Neurochemistry. 105: 1235-43. PMID 18194436 DOI: 10.1111/j.1471-4159.2008.05225.x  0.36
2008 Chandran JS, Lin X, Zapata A, Höke A, Shimoji M, Moore SO, Galloway MP, Laird FM, Wong PC, Price DL, Bailey KR, Crawley JN, Shippenberg T, Cai H. Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiology of Disease. 29: 505-14. PMID 18187333 DOI: 10.1016/j.nbd.2007.11.011  0.36
2008 Schepers RJ, Mahoney JL, Zapata A, Chefer V, Shippenberg TS. The effects of local perfusion of DAMGO on extracellular GABA and glutamate concentrations in the rostral ventromedial medulla. Journal of Neurochemistry. 104: 806-17. PMID 17961151 DOI: 10.1111/j.1471-4159.2007.05017.x  0.36
2008 Schepers RJ, Mahoney JL, Shippenberg TS. Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception. Pain. 136: 320-30. PMID 17764840 DOI: 10.1016/j.pain.2007.07.010  0.36
2007 Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. The Journal of Biological Chemistry. 282: 35842-54. PMID 17923483 DOI: 10.1074/jbc.M611758200  0.36
2007 Shippenberg TS, Zapata A, Chefer VI. Dynorphin and the pathophysiology of drug addiction. Pharmacology & Therapeutics. 116: 306-21. PMID 17868902 DOI: 10.1016/j.pharmthera.2007.06.011  0.36
2007 Oz M, Yang KH, Dinc M, Shippenberg TS. The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. The Journal of Pharmacology and Experimental Therapeutics. 323: 547-54. PMID 17682128 DOI: 10.1124/jpet.107.125336  0.36
2007 Oz M, Yang KH, Shippenberg TS, Renaud LP, O'Donovan MJ. Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons. Journal of Neurophysiology. 98: 1108-14. PMID 17581850 DOI: 10.1152/jn.00148.2007  0.36
2007 Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32. PMID 17267664 DOI: 10.1124/mol.106.027763  0.36
2007 Riegel AC, Zapata A, Shippenberg TS, French ED. The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1558-69. PMID 17213847 DOI: 10.1038/sj.npp.1301273  0.36
2007 Barbier E, Zapata A, Oh E, Liu Q, Zhu F, Undie A, Shippenberg T, Wang JB. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1774-82. PMID 17203012 DOI: 10.1038/sj.npp.1301301  0.36
2007 Kaminski RM, Witkin JM, Shippenberg TS. Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling. Neuropharmacology. 52: 895-903. PMID 17126860 DOI: 10.1016/j.neuropharm.2006.10.007  0.36
2006 Bruening S, Oh E, Hetzenauer A, Escobar-Alvarez S, Westphalen RI, Hemmings HC, Singewald N, Shippenberg T, Toth M. The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system. Journal of Neurochemistry. 99: 892-9. PMID 16925594 DOI: 10.1111/j.1471-4159.2006.04129.x  0.36
2006 Doyon WM, Howard EC, Shippenberg TS, Gonzales RA. Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology. 51: 487-96. PMID 16781738 DOI: 10.1016/j.neuropharm.2006.04.005  0.36
2006 Woods AS, Kaminski R, Oz M, Wang Y, Hauser K, Goody R, Wang HY, Jackson SN, Zeitz P, Zeitz KP, Zolkowska D, Schepers R, Nold M, Danielson J, Gräslund A, ... ... Shippenberg T, et al. Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity. Journal of Proteome Research. 5: 1017-23. PMID 16602711 DOI: 10.1021/pr060016+  0.36
2006 Zapata A, Shippenberg TS. Endogenous kappa opioid receptor systems modulate the responsiveness of mesoaccumbal dopamine neurons to ethanol. Alcoholism, Clinical and Experimental Research. 30: 592-7. PMID 16573576 DOI: 10.1111/j.1530-0277.2006.00069.x  0.36
2006 Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America. 103: 2938-42. PMID 16477003 DOI: 10.1073/pnas.0511159103  0.36
2006 Chefer VI, Zapata A, Shippenberg TS, Bungay PM. Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. Journal of Neuroscience Methods. 155: 187-93. PMID 16466808 DOI: 10.1016/j.jneumeth.2005.12.018  0.36
2006 Chefer VI, Shippenberg TS. Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. The European Journal of Neuroscience. 23: 229-38. PMID 16420432 DOI: 10.1111/j.1460-9568.2005.04525.x  0.36
2006 Zapata A, Gonzales RA, Shippenberg TS. Repeated ethanol intoxication induces behavioral sensitization in the absence of a sensitized accumbens dopamine response in C57BL/6J and DBA/2J mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 396-405. PMID 16034441 DOI: 10.1038/sj.npp.1300833  0.36
2005 Kaminski RM, Shippenberg TS, Witkin JM, Rocha BA. Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures. Neuroscience Letters. 382: 51-5. PMID 15911120 DOI: 10.1016/j.neulet.2005.02.056  0.36
2005 Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS. Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5029-37. PMID 15901784 DOI: 10.1523/JNEUROSCI.0854-05.2005  0.36
2005 Zapata A, Shippenberg TS. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels. Neuropharmacology. 48: 43-50. PMID 15617726 DOI: 10.1016/j.neuropharm.2004.09.003  0.36
2005 Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, Knapp PE, Scheff SW, Singh IN, Vissel B, Woods AS, Yakovleva T, Shippenberg TS. Pathobiology of dynorphins in trauma and disease. Frontiers in Bioscience : a Journal and Virtual Library. 10: 216-35. PMID 15574363  0.36
2004 Chefer VI, Kieffer BL, Shippenberg TS. Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine. Neuroscience. 127: 497-503. PMID 15262338 DOI: 10.1016/j.neuroscience.2004.05.021  0.36
2004 Oz M, Woods AS, Shippenberg T, Kaminski RM. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Synapse (New York, N.Y.). 52: 84-8. PMID 15034914 DOI: 10.1002/syn.20009  0.36
2004 Oz M, Zakharova I, Dinc M, Shippenberg T. Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 252-9. PMID 14652711 DOI: 10.1007/s00210-003-0838-9  0.36
2003 Chefer VI, Kieffer BL, Shippenberg TS. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. The European Journal of Neuroscience. 18: 1915-22. PMID 14622224 DOI: 10.1046/j.1460-9568.2003.02912.x  0.36
2003 Morón JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A, Shippenberg TS. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8480-8. PMID 13679416  0.36
2003 Taltavull JF, Chefer VI, Shippenberg TS, Kiyatkin EA. Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim. Brain Research. 975: 244-7. PMID 12763614 DOI: 10.1016/S0006-8993(03)02695-7  0.36
2003 Chefer VI, Zakharova I, Shippenberg TS. Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 3076-84. PMID 12684494  0.36
2003 Zapata A, Chefer VI, Ator R, Shippenberg TS, Rocha BA. Behavioural sensitization and enhanced dopamine response in the nucleus accumbens after intravenous cocaine self-administration in mice. The European Journal of Neuroscience. 17: 590-6. PMID 12581176 DOI: 10.1046/j.1460-9568.2003.02491.x  0.36
2002 Witkin JM, Gasior M, Schad C, Zapata A, Shippenberg T, Hartman T, Slusher BS. NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Neuropharmacology. 43: 348-56. PMID 12243764 DOI: 10.1016/S0028-3908(02)00124-7  0.36
2002 Basile AS, Fedorova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proceedings of the National Academy of Sciences of the United States of America. 99: 11452-7. PMID 12154229 DOI: 10.1073/pnas.162371899  0.36
2002 Chefer VI, Shippenberg TS. Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience. 112: 907-19. PMID 12088750 DOI: 10.1016/S0306-4522(02)00099-4  0.36
2002 Carvelli L, Morón JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lundberg LM, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A. PI 3-kinase regulation of dopamine uptake. Journal of Neurochemistry. 81: 859-69. PMID 12065645 DOI: 10.1046/j.1471-4159.2002.00892.x  0.36
2002 Zapata A, Shippenberg TS. D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens. Journal of Neurochemistry. 81: 1035-42. PMID 12065616 DOI: 10.1046/j.1471-4159.2002.00893.x  0.36
2002 De Vries TJ, Shippenberg TS. Neural systems underlying opiate addiction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3321-5. PMID 11978806  0.36
2002 Daws LC, Callaghan PD, Morón JA, Kahlig KM, Shippenberg TS, Javitch JA, Galli A. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochemical and Biophysical Research Communications. 290: 1545-50. PMID 11820798 DOI: 10.1006/bbrc.2002.6384  0.36
2001 Thompson AC, Shippenberg TS. Microdialysis in rodents. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit7.2. PMID 18428530 DOI: 10.1002/0471142301.ns0702s00  0.36
2001 Shippenberg TS, Thompson AC. Overview of microdialysis. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit7.1. PMID 18428520 DOI: 10.1002/0471142301.ns0701s00  0.36
2001 Zapata A, Witkin JM, Shippenberg TS. Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology. 41: 351-9. PMID 11522326 DOI: 10.1016/S0028-3908(01)00069-7  0.36
2001 Shippenberg TS, Chefer VI, Zapata A, Heidbreder CA. Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems. Annals of the New York Academy of Sciences. 937: 50-73. PMID 11458540  0.36
2001 He M, Sibille E, Benjamin D, Toth M, Shippenberg T. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Research. 902: 11-7. PMID 11376590 DOI: 10.1016/S0006-8993(01)02271-5  0.36
2001 Burgdorf J, Knutson B, Panksepp J, Shippenberg TS. Evaluation of rat ultrasonic vocalizations as predictors of the conditioned aversive effects of drugs. Psychopharmacology. 155: 35-42. PMID 11374334 DOI: 10.1007/s002130100685  0.36
2001 Schenk S, Partridge B, Shippenberg TS. Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 441-50. PMID 11182539 DOI: 10.1016/S0893-133X(00)00190-1  0.36
2001 Acri JB, Thompson AC, Shippenberg T. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Synapse (New York, N.Y.). 39: 343-50. PMID 11169785 DOI: 10.1002/1098-2396(20010315)39:4<343::AID-SYN1018>3.0.CO;2-Q  0.36
2000 Thompson AC, Zapata A, Justice JB, Vaughan RA, Sharpe LG, Shippenberg TS. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 9333-40. PMID 11125013  0.36
2000 Chefer VI, Morón JA, Hope B, Rea W, Shippenberg TS. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience. 101: 619-27. PMID 11113311 DOI: 10.1016/S0306-4522(00)00417-6  0.36
2000 Shippenberg TS, Funada M, Schutz CG. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat. Psychopharmacology. 151: 351-8. PMID 11026742 DOI: 10.1007/s002130000475  0.36
2000 Chou YH, Halldin C, Farde L. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study. Synapse (New York, N.Y.). 38: 138-43. PMID 11018787 DOI: 10.1002/1098-2396(200011)38:2<138::AID-SYN4>3.0.CO;2-7  0.36
2000 Schenk S, Partridge B, Shippenberg TS. Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology. 151: 85-90. PMID 10958121 DOI: 10.1007/s002130000476  0.36
2000 Sharpe LG, Pilotte NS, Shippenberg TS, Goodman CB, London ED. Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain. Synapse (New York, N.Y.). 37: 292-7. PMID 10891866 DOI: 10.1002/1098-2396(20000915)37:4<292::AID-SYN6>3.0.CO;2-V  0.36
2000 Shippenberg TS, Hen R, He M. Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor. Journal of Neurochemistry. 75: 258-65. PMID 10854269  0.36
2000 El Daly E, Chefer V, Sandill S, Shippenberg TS. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593. Journal of Neurochemistry. 74: 1553-62. PMID 10737612 DOI: 10.1046/j.1471-4159.2000.0741553.x  0.36
2000 He M, Shippenberg TS. Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum. The Journal of Pharmacology and Experimental Therapeutics. 293: 121-7. PMID 10734161  0.36
1999 Shippenberg TS, He M, Chefer V. The use of microdialysis in the mouse: conventional versus quantitative techniques. Psychopharmacology. 147: 33-4. PMID 10591865 DOI: 10.1007/s002130051138  0.36
1999 Stöhr T, Almeida OF, Landgraf R, Shippenberg TS, Holsboer F, Spanagel R. Stress- and corticosteroid-induced modulation of the locomotor response to morphine in rats. Behavioural Brain Research. 103: 85-93. PMID 10475168 DOI: 10.1016/S0166-4328(99)00027-3  0.36
1999 Gray AM, Rawls SM, Shippenberg TS, McGinty JF. The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. Journal of Neurochemistry. 73: 1066-74. PMID 10461896 DOI: 10.1046/j.1471-4159.1999.0731066.x  0.36
1999 Schenk S, Partridge B, Shippenberg TS. U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology. 144: 339-46. PMID 10435406 DOI: 10.1007/s002130051016  0.36
1999 Chen L, He M, Sibille E, Thompson A, Sarnyai Z, Baker H, Shippenberg T, Toth M. Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B. Journal of Neurochemistry. 73: 647-55. PMID 10428061 DOI: 10.1046/j.1471-4159.1999.0730647.x  0.36
1999 Chefer V, Thompson AC, Shippenberg TS. Modulation of cocaine-induced sensitization by kappa-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex. Annals of the New York Academy of Sciences. 877: 803-6. PMID 10415709 DOI: 10.1111/j.1749-6632.1999.tb09327.x  0.36
1999 Witkin JM, Savtchenko N, Mashkovsky M, Beekman M, Munzar P, Gasior M, Goldberg SR, Ungard JT, Kim J, Shippenberg T, Chefer V. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 288: 1298-310. PMID 10027871  0.36
1998 Shippenberg TS, Elmer GI. The neurobiology of opiate reinforcement. Critical Reviews in Neurobiology. 12: 267-303. PMID 10348612  0.36
1998 Izenwasser S, Acri JB, Kunko PM, Shippenberg T. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Synapse (New York, N.Y.). 30: 275-83. PMID 9776131 DOI: 10.1002/(SICI)1098-2396(199811)30:3<275::AID-SYN5>3.0.CO;2-8  0.36
1998 Heidbreder CA, Schenk S, Partridge B, Shippenberg TS. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse (New York, N.Y.). 30: 255-62. PMID 9776129 DOI: 10.1002/(SICI)1098-2396(199811)30:3<255::AID-SYN3>3.0.CO;2-A  0.36
1998 Rea WP, Rothman RB, Shippenberg TS. Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies. Synapse (New York, N.Y.). 30: 107-11. PMID 9704887 DOI: 10.1002/(SICI)1098-2396(199809)30:1<107::AID-SYN13>3.0.CO;2-1  0.36
1998 Rothman RB, Elmer GI, Shippenberg TS, Rea W, Baumann MH. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction. Annals of the New York Academy of Sciences. 844: 59-74. PMID 9668665 DOI: 10.1111/j.1749-6632.1998.tb08222.x  0.36
1998 De Vries TJ, Cools AR, Shippenberg TS. Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization. Neuroreport. 9: 1763-8. PMID 9665597  0.36
1998 Shippenberg TS, LeFevour A, Thompson AC. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593. European Journal of Pharmacology. 345: 27-34. PMID 9593590 DOI: 10.1016/S0014-2999(97)01614-2  0.36
1997 Shippenberg TS, Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacology, Biochemistry, and Behavior. 57: 449-55. PMID 9218269 DOI: 10.1016/S0091-3057(96)00450-9  0.36
1996 Funada M, Shippenberg TS. Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behavioural Pharmacology. 7: 448-453. PMID 11224440  0.36
1996 Shoaib M, Shippenberg TS. Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats. Psychopharmacology. 128: 343-50. PMID 8986004 DOI: 10.1007/s002130050143  0.36
1996 Shippenberg TS, Heidbreder C, Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. European Journal of Pharmacology. 299: 33-9. PMID 8901005 DOI: 10.1016/0014-2999(95)00852-7  0.36
1996 Heidbreder CA, Shippenberg TS. Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse (New York, N.Y.). 24: 182-92. PMID 8890460 DOI: 10.1002/(SICI)1098-2396(199610)24:2<182::AID-SYN10>3.0.CO;2-0  0.36
1996 Heidbreder C, Shoaib M, Shippenberg TS. Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine. European Journal of Pharmacology. 298: 207-16. PMID 8846818 DOI: 10.1016/0014-2999(95)00815-2  0.36
1996 Heidbreder CA, Thompson AC, Shippenberg TS. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. The Journal of Pharmacology and Experimental Therapeutics. 278: 490-502. PMID 8768696  0.36
1996 Funada M, Schutz CG, Shippenberg TS. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. European Journal of Pharmacology. 300: 17-24. PMID 8741160 DOI: 10.1016/0014-2999(95)00860-8  0.36
1996 Shippenberg TS, LeFevour A, Heidbreder C. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 276: 545-54. PMID 8632320  0.36
1995 Shoaib M, Shippenberg TS, Goldberg SR, Schindler CW. Behavioral studies with the glycine partial agonist (+)-HA966 on cocaine-induced locomotor activity and reinforcement. Behavioural Pharmacology. 6: 568-576. PMID 11224364  0.36
1995 Shippenberg TS, Bals-Kubik R. Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behavioural Pharmacology. 6: 99-106. PMID 11224316  0.36
1995 de Vries TJ, Babovic-Vuksanovic D, Elmer G, Shippenberg TS. Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology. 120: 442-8. PMID 8539325 DOI: 10.1007/BF02245816  0.36
1995 Shoaib M, Spanagel R, Stohr T, Shippenberg TS. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats. Psychopharmacology. 117: 240-7. PMID 7753973 DOI: 10.1007/BF02245193  0.36
1995 Shippenberg TS, Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. The Journal of Pharmacology and Experimental Therapeutics. 273: 808-15. PMID 7752084  0.36
1995 Heidbreder CA, Babovic-Vuksanovic D, Shoaib M, Shippenberg TS. Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists. The Journal of Pharmacology and Experimental Therapeutics. 275: 150-63. PMID 7562544  0.36
1995 Shippenberg TS, Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. European Journal of Pharmacology. 280: 55-61. PMID 7498254 DOI: 10.1016/0014-2999(95)00185-N  0.36
1994 Spanagel R, Almeida OF, Bartl C, Shippenberg TS. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology. 115: 121-7. PMID 7862883 DOI: 10.1007/BF02244761  0.36
1994 Spanagel R, Almeida OF, Shippenberg TS. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. European Journal of Pharmacology. 264: 157-62. PMID 7851478 DOI: 10.1016/0014-2999(94)00449-8  0.36
1994 Heidbreder CA, Shippenberg TS. U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. Neuroreport. 5: 1797-800. PMID 7827335  0.36
1993 Heidbreder CA, Goldberg SR, Shippenberg TS. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Research. 616: 335-8. PMID 8395306 DOI: 10.1016/0006-8993(93)90228-F  0.36
1993 Spanagel R, Shippenberg TS. Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. Neuroscience Letters. 153: 232-6. PMID 8392157 DOI: 10.1016/0304-3940(93)90329-J  0.36
1993 Shippenberg TS, Bals-Kubik R, Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. The Journal of Pharmacology and Experimental Therapeutics. 265: 53-9. PMID 8386244  0.36
1993 Heidbreder C, Goldberg SR, Shippenberg TS. Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. European Journal of Pharmacology. 243: 123-7. PMID 8276060 DOI: 10.1016/0014-2999(93)90370-W  0.36
1993 Spanagel R, Almeida OF, Shippenberg TS. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse (New York, N.Y.). 14: 243-5. PMID 8211708 DOI: 10.1002/syn.890140307  0.36
1993 Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. The Journal of Pharmacology and Experimental Therapeutics. 264: 489-95. PMID 8093731  0.36
1993 Spanagel R, Herz A, Shippenberg TS. Dopamine release in the mesolimbic system is modulated by opposing endogenous opioid systems Nida Research Monograph Series. 109.  0.36
1992 Ayesta FJ, Ableitner A, Emmett-Oglesby MW, Herz A, Shippenberg TS. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation. The Journal of Pharmacology and Experimental Therapeutics. 260: 168-74. PMID 1731036  0.36
1992 Herz A, Shippenberg TS, Bals-Kubik R, Spanagel R. [Opiate addiction. Pharmacologic and biochemical aspects]. Arzneimittel-Forschung. 42: 256-9. PMID 1586396  0.36
1992 Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America. 89: 2046-50. PMID 1347943  0.36
1992 Shippenberg TS, Herz A, Spanagel R, Bals-Kubik R, Stein C. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Annals of the New York Academy of Sciences. 654: 347-56. PMID 1321576  0.36
1991 Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS. Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology. 104: 51-6. PMID 1882003 DOI: 10.1007/BF02244553  0.36
1991 Shippenberg TS, Herz A. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 256: 1101-6. PMID 1848627  0.36
1991 Shippenberg TS, Bals-Kubik R, Huber A, Herz A. Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology. 103: 209-14. PMID 1827526 DOI: 10.1007/BF02244205  0.36
1991 Shippenberg TS. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors. Neuroscience Letters. 121: 136-8. PMID 1826942 DOI: 10.1016/0304-3940(91)90668-J  0.36
1991 Spanagel R, Herz A, Shippenberg TS. Modulation of the mesolimbic dopaminergic system by beta-endorphin-(1-27) as assessed by microdialysis. European Journal of Pharmacology. 200: 319-24. PMID 1782993 DOI: 10.1016/0014-2999(91)90589-I  0.36
1991 Shippenberg TS, Herz A, Nikolarakis K. Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus. Brain Research. 563: 209-14. PMID 1686211 DOI: 10.1016/0006-8993(91)91535-9  0.36
1990 Spanagel R, Herz A, Shippenberg TS. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. European Journal of Pharmacology. 190: 177-84. PMID 1981749 DOI: 10.1016/0014-2999(90)94124-G  0.36
1990 Spanagel R, Herz A, Shippenberg TS. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. Journal of Neurochemistry. 55: 1734-40. PMID 1976759  0.36
1990 Bals-Kubik R, Shippenberg TS, Herz A. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. European Journal of Pharmacology. 175: 63-9. PMID 1969799  0.36
1990 Herz A, Bals-Kubik R, Spanagel R, Shippenberg T. Neurochemical aspects of opioid addiction European Journal of Pharmacology. 183: 140.  0.36
1990 Bals-Kubik R, Shippenberg TS, Herz A. Neuroanatomical substrates mediating the motivational effects of opioids New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 11.  0.36
1990 Shippenberg TS, Herz A, Nikolarakis KE. Influence of Freund's adjuvant-induced inflammatory pain upon opioid peptide release in the hypothalamus European Journal of Pharmacology. 183: 973-974.  0.36
1989 Shippenberg TS, Emmett-Oglesby MW, Herz A. Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity. Pharmacology, Biochemistry, and Behavior. 32: 129-32. PMID 2734325 DOI: 10.1016/0091-3057(89)90221-9  0.36
1989 Bals-Kubik R, Herz A, Shippenberg TS. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology. 98: 203-6. PMID 2569217 DOI: 10.1007/BF00444692  0.36
1989 Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. The Journal of Pharmacology and Experimental Therapeutics. 248: 1269-75. PMID 2539460  0.36
1988 Emmett-Oglesby MW, Shippenberg TS, Herz A. Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine. The Journal of Pharmacology and Experimental Therapeutics. 245: 17-23. PMID 3361440  0.36
1988 Stein C, Millan MJ, Shippenberg TS, Herz A. Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neuroscience Letters. 84: 225-8. PMID 3340329 DOI: 10.1016/0304-3940(88)90412-0  0.36
1988 Shippenberg TS, Emmett-Oglesby MW, Ayesta FJ, Herz A. Tolerance and selective cross-tolerance to the motivational effects of opioids. Psychopharmacology. 96: 110-5. PMID 3147470 DOI: 10.1007/BF02431542  0.36
1988 Bals-Kubik R, Herz A, Shippenberg TS. Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 392-6. PMID 2854207 DOI: 10.1007/BF00172115  0.36
1988 Shippenberg TS, Stein C, Huber A, Millan MJ, Herz A. Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists. Pain. 35: 179-86. PMID 2853321 DOI: 10.1016/0304-3959(88)90225-4  0.36
1988 Shippenberg TS, Millan MJ, Mucha RF, Herz A. Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat. European Journal of Pharmacology. 154: 135-44. PMID 2852596 DOI: 10.1016/0014-2999(88)90090-8  0.36
1988 Shippenberg TS, Herz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. European Journal of Pharmacology. 151: 233-42. PMID 2844553 DOI: 10.1016/0014-2999(88)90803-5  0.36
1988 Shippenberg T, Bals-Kubik R, Herz A. Endogenous opioids and reinforcement: Role of multiple opioid receptor types and dopamine Nida Research Monograph Series. 40.  0.36
1987 Shippenberg TS, Herz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Brain Research. 436: 169-72. PMID 2961413 DOI: 10.1016/0006-8993(87)91571-X  0.36
1987 Shippenberg T, Herz A. Motivational properties of opioids. Polish Journal of Pharmacology and Pharmacy. 39: 577-83. PMID 2852365  0.36
1987 Shippenberg TS, Bals-Kubik R, Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Research. 436: 234-9. PMID 2829990 DOI: 10.1016/0006-8993(87)91667-2  0.36
1986 Shippenberg TS, Herz A. Differential effects of mu and kappa opioid systems on motivational processes. Nida Research Monograph. 75: 563-66. PMID 2829003  0.36
1985 Shippenberg TS, Altshuler HL. A drug discrimination analysis of ethanol-induced behavioral excitation and sedation: the role of endogenous opiate pathways. Alcohol (Fayetteville, N.Y.). 2: 197-201. PMID 4015843 DOI: 10.1016/0741-8329(85)90045-X  0.36
1982 Altshuler HL, Shippenberg TS. Tetrahydroisoquinoline and opioid substrates of alcohol actions. Progress in Clinical and Biological Research. 90: 329-44. PMID 7202207  0.36
1982 Shippenberg TS, Altshuler LH. Electroencephalographic effects of alcohol, opiate peptides and tetrahydroisoquinolines Federation Proceedings. 41: 6987.  0.36
1981 Altshuler HL, Applebaum E, Shippenberg TS. The effects of opiate antagonists on the discriminative stimulus properties of ethanol. Pharmacology, Biochemistry, and Behavior. 14: 97-100. PMID 7465612 DOI: 10.1016/0091-3057(81)90109-X  0.36
1981 Altshuler HL, Shippenberg TS. A subhuman primate model for fetal alcohol syndrome research. Neurobehavioral Toxicology and Teratology. 3: 121-6. PMID 7254459  0.36
1981 Altshuler HL, Shippenberg T, Lee D. The discriminative stimulus properties of ethanol: TIQ and opiate mechanisms Alcoholism: Clinical and Experimental Research. 5: No.5.  0.36
Show low-probability matches.